Profil
Dr. Eric von Hofe is a Vice President at Generex Biotechnology Corp.
and a Chief Executive Officer at CellXLife.
Dr. von Hofe was previously employed as a President & Chief Operating Officer by Affyimmune Therapeutics, Inc., a Director-New Targets by Idera Pharmaceuticals, Inc., a Director-Programs & Operations by Millennium Pharmaceuticals, Inc., a President & Chief Scientific Officer by NuGenerex Immuno-Oncology, Inc., and an Assistant Professor-Pharmacology by University of Massachusetts.
He received his doctorate degree from the University of Southern California.
Aktiva positioner av Eric von Hofe
| Företag | Position | Start |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Företagsledare/Principal | 2005-01-01 |
Tidigare kända positioner av Eric von Hofe
| Företag | Position | Slut |
|---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | President | - |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | President | - |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Företagsledare/Principal | - |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Verksamhetschef | - |
Eric von Hofes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and commercialization of drug delivery systems & technologies | Commercial Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products and vaccines for the treatment of cancer diseases | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Commercial Services |
















